TR199903209T2 - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
TR199903209T2
TR199903209T2 TR1999/03209T TR9903209T TR199903209T2 TR 199903209 T2 TR199903209 T2 TR 199903209T2 TR 1999/03209 T TR1999/03209 T TR 1999/03209T TR 9903209 T TR9903209 T TR 9903209T TR 199903209 T2 TR199903209 T2 TR 199903209T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
invention describes
words
composition
steroid
Prior art date
Application number
TR1999/03209T
Other languages
Turkish (tr)
Inventor
Frank Parr Alan
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199903209T2 publication Critical patent/TR199903209T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Abstract

Bu bulus, bir farmasötik açidan aktif aza steroidin terapötik açidan etkili bir miktarini ve gliserol ya da propilen glikolün bir yagli asit esterini içeren bir yeni çözeltiyi anlatmaktadir. Bir baska yaninda ise, bu bulus, bulusun çözeltilerini içeren bir farmasötik bilesimi anlatmaktadir. Bir baska yaninda, bu bulus, bu bulusun bilesimi ile doldurulmus bir jelatin kapsülü anlatmaktadir.This invention describes a therapeutically effective amount of a pharmaceutically active or steroid and a new solution containing a fatty acid ester of glycerol or propylene glycol. In other words, this invention describes a pharmaceutical composition comprising the solutions of the invention. In other words, this invention describes a gelatin capsule filled with the composition of this invention.

TR1999/03209T 1997-08-19 1998-08-17 Pharmaceutical composition. TR199903209T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TR199903209T2 true TR199903209T2 (en) 2000-05-22

Family

ID=10817619

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03209T TR199903209T2 (en) 1997-08-19 1998-08-17 Pharmaceutical composition.

Country Status (15)

Country Link
EP (1) EP1007010A2 (en)
JP (1) JP2002511101A (en)
KR (1) KR20010014080A (en)
CN (1) CN1263461A (en)
AR (1) AR016629A1 (en)
AU (1) AU9343098A (en)
BR (1) BR9810458A (en)
CA (1) CA2295016A1 (en)
CO (1) CO4960657A1 (en)
GB (1) GB9717428D0 (en)
MA (1) MA26531A1 (en)
PE (1) PE105699A1 (en)
TR (1) TR199903209T2 (en)
WO (1) WO1999008666A2 (en)
ZA (1) ZA987392B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (en) * 2002-11-22 2004-05-23 Omega Farma Ehf. Compositions of finasteride tablets
PL1660047T3 (en) 2003-08-13 2014-05-30 Biocon Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2005066195A1 (en) * 2004-01-02 2005-07-21 Pharmacon Forschung Und Beratung Gmbh Method for producing 1,2-unsaturated azasteroids
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
WO2010117873A2 (en) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Progesterone solutions for increased bioavailability
ES2385240B1 (en) 2010-07-26 2013-09-23 Gp-Pharm, S.A. CAPSULES OF ACTIVE PHARMACEUTICAL PRINCIPLES AND POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF PROSTATE DISEASES.
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
CN103169712B (en) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 Improve dutasteride's preparation of bioavilability and preparation method thereof
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
ES2555485T1 (en) 2014-05-26 2016-01-04 Galenicum Health S.L. Pharmaceutical compositions containing an active agent
KR101679992B1 (en) * 2015-12-31 2016-11-28 주식회사 유유제약 Pharmaceutical composition comprising dutasteride and propylene glycol monolaurate and preparation method of the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (en) * 1986-03-06 1987-09-10 Schering Ag COMBINATION OF AROMATASE INHIBITORS AND TESTOSTERONE-5 (ALPHA) REDUCTASE INHIBITORS
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
GB9717428D0 (en) 1997-10-22
CA2295016A1 (en) 1999-02-25
BR9810458A (en) 2000-09-05
KR20010014080A (en) 2001-02-26
WO1999008666A2 (en) 1999-02-25
CO4960657A1 (en) 2000-09-25
EP1007010A2 (en) 2000-06-14
AU9343098A (en) 1999-03-08
JP2002511101A (en) 2002-04-09
MA26531A1 (en) 2004-12-20
PE105699A1 (en) 1999-11-25
AR016629A1 (en) 2001-07-25
ZA987392B (en) 2000-02-17
CN1263461A (en) 2000-08-16
WO1999008666A3 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
ES530270A0 (en) A PHARMACEUTICAL UNITARY DOSAGE FORM
TR200003666T2 (en) Formoterol for the prevention, treatment of an acute case of asthma
TR199903209T2 (en) Pharmaceutical composition.
TR200100931T2 (en) New sustained release oral formulations
TR200000517T2 (en) Pharmaceutical composition for the combination of piperidinoalkanol-Congestion reducer.
TR200103039T2 (en) Pharmaceutical composition in a unit form containing acetylsalicylic acid and clopidogrel hydrogenosulfate.
TR200101333T2 (en) Pharmaceutical composition for modified release of an insulin sensitiser and another anti-diabetic agent.
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
DE69942154D1 (en) MEDICATION-COMPATIBLE COMPOSITION IN AEROSOL FORM
ATE204751T1 (en) AGENTS FOR DELIVERY OF MEDICINAL IN THE COLON
TR199800648A1 (en) Medication system for two or more active ingredients.
ES2176684T3 (en) NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC.
NO20005394L (en) Drug delivery compositions comprising adhesive microspheres
TR199903211T2 (en) Solutions containing azasteroids.
TR199902175T2 (en) Swallowing tablet containing paracetamol.
TR199900789T2 (en) Pharmaceutical microspheres containing valproic acid for oral administration.
TR199901413T2 (en) New treatment for joint inflammation.
DE3587698T2 (en) Pharmaceutical preparations.
BR0111678A (en) Medicinal compositions containing propenone derivatives
TR200100361T2 (en) New oral formulation
TR199800526T2 (en) Soft capsule preparations containing cyclosporine.
CO4970832A1 (en) NEW FORMULATIONS AND PROCESSES FOR ITS MANUFACTURE
TR200200683T2 (en) Oral controlled release formulations.
AR002735A1 (en) LIQUID FORMULATIONS OF ACTIVE INSECTICIDAL SUBSTANCES.
DK0555317T3 (en) Phospholipid analog vesicle with a succinimidyl substituent